Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Akihiro Moriuchi"'
Autor:
Seiichi Mawatari, Kotaro Kumagai, Kohei Oda, Kazuaki Tabu, Sho Ijuin, Kunio Fujisaki, Shuzo Tashima, Yukiko Inada, Hirofumi Uto, Akiko Saisyoji, Yasunari Hiramine, Masafumi Hashiguchi, Tsutomu Tamai, Takeshi Hori, Ohki Taniyama, Ai Toyodome, Haruka Sakae, Takeshi Kure, Kazuhiro Sakurai, Akihiro Moriuchi, Shuji Kanmura, Akio Ido
Publikováno v:
PLoS ONE, Vol 17, Iss 1 (2022)
Background The features of hepatitis C virus patients with a sustained virologic response (SVR) who developed hepatocellular carcinoma (HCC) after direct-acting antiviral (DAA) therapy are unclear. Methods The study population included 1494 DAA-SVR p
Externí odkaz:
https://doaj.org/article/a9d631c3572b48d2b03ea489655c1018
Autor:
Nobuyuki Koriyama, Akihiro Moriuchi, Kensaku Higashi, Tetsuro Kataoka, Takuro Arimizu, Go Takaguchi, Hideki Matsuoka, Maki Otsuka
Publikováno v:
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Vol 16 (2022)
BACKGROUND In COVID-19 pneumonia, cases of severe hypoxemia in the early stage and cases of sudden deterioration in respiratory status due to silent hypoxia leading to death, have been reported. CASE SUMMARY A 70-year-old Japanese man with essential
Externí odkaz:
https://doaj.org/article/0c93e0d609bc40ba8b9d2567a858eaba
Autor:
Kazuaki Tabu, Seiichi Mawatari, Kohei Oda, Kotaro Kumagai, Yukiko Inada, Hirofumi Uto, Akiko Saisyoji, Yasunari Hiramine, Masafumi Hashiguchi, Tsutomu Tamai, Takeshi Hori, Kunio Fujisaki, Dai Imanaka, Takeshi Kure, Ohki Taniyama, Ai Toyodome, Sho Ijuin, Haruka Sakae, Kazuhiro Sakurai, Akihiro Moriuchi, Shuji Kanmura, Akio Ido
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237475 (2020)
Background and aimsDirect-acting antivirals (DAAs) against hepatitis C virus (HCV) exert high anti-HCV activity and are expected to show anti-inflammatory effects associated with HCV elimination. Furthermore, hepatocellular carcinoma (HCC) is known t
Externí odkaz:
https://doaj.org/article/77e19cc7fd2f44569864b15ba39951ef
Autor:
Kotaro Kumagai, Seiichi Mawatari, Akihiro Moriuchi, Kohei Oda, Yasuhiro Takikawa, Naoya Kato, Shigeto Oda, Kazuaki Inoue, Shuji Terai, Takuya Genda, Masahito Shimizu, Isao Sakaida, Satoshi Mochida, Akio Ido
Publikováno v:
Hepatology Research. 53:160-171
We investigated whether an early-phase prothrombin time-international normalized ratio (PT-INR) is an interventional prognostic indicator for patients with acute liver injury, including acute liver failure.This was a multicenter retrospective observa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfa9b41ed264554ddd156e594f710e90
https://doi.org/10.1111/hepr.13848
https://doi.org/10.1111/hepr.13848
Autor:
Yuki Tahata, Hayato Hikita, Satoshi Mochida, Nobuyuki Enomoto, Norifumi Kawada, Masayuki Kurosaki, Akio Ido, Daiki Miki, Hitoshi Yoshiji, Yasuhiro Takikawa, Ryotaro Sakamori, Yoichi Hiasa, Kazuhiko Nakao, Naoya Kato, Yoshiyuki Ueno, Hiroshi Yatsuhashi, Yoshito Itoh, Ryosuke Tateishi, Goki Suda, Taro Takami, Yasunari Nakamoto, Yasuhiro Asahina, Kentaro Matsuura, Taro Yamashita, Tatsuya Kanto, Norio Akuta, Shuji Terai, Masahito Shimizu, Satoshi Sobue, Tomokatsu Miyaki, Akihiro Moriuchi, Ryoko Yamada, Takahiro Kodama, Tomohide Tatsumi, Tomomi Yamada, Tetsuo Takehara
Publikováno v:
Journal of Gastroenterology. 57:120-132
Direct-acting antiviral (DAA) therapy enables a high rate of sustained virologic response (SVR) in patients with hepatitis C virus associated cirrhosis. However, the impact of DAA therapy on liver-related events in patients with cirrhosis is unclear.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24cf3335cff0c2868f28bfc325b09f8c
https://doi.org/10.1007/s00535-021-01845-5
https://doi.org/10.1007/s00535-021-01845-5
Autor:
Seiichi Mawatari, Kohei Oda, Kazuaki Tabu, Sho Ijuin, Kotaro Kumagai, Kunio Fujisaki, Masafumi Hashiguchi, Yukiko Inada, Hirofumi Uto, Yasunari Hiramine, Takeshi Kure, Takeshi Hori, Oki Taniyama, Ai Kasai, Tsutomu Tamai, Akihiro Moriuchi, Akio Ido
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198642 (2018)
OBJECTIVE:The present study aimed to reveal the factors associated with virologic failure in sofosbuvir and ledipasvir (SOF/LDV)-treated patients, and identify baseline NS5A or NS5B resistance-associated substitutions (RASs). METHODS:Four hundred nin
Externí odkaz:
https://doaj.org/article/dd5b56e94e8f4b56a63aad408af02b30
Autor:
Seiichi Mawatari, Tsutomu Tamai, Kotaro Kumagai, Akiko Saisyoji, Kaori Muromachi, Ai Toyodome, Ohki Taniyama, Haruka Sakae, Sho Ijuin, Kazuaki Tabu, Kohei Oda, Yasunari Hiramine, Akihiro Moriuchi, Kazuhiro Sakurai, Shuji Kanmura, Akio Ido
Publikováno v:
Cancers; Volume 14; Issue 24; Pages: 6139
The present study clarified the prognosis of intermediate-stage hepatocellular carcinoma (HCC) patients who received lenvatinib (LEN) followed by transcatheter arterial chemoembolization (TACE) on demand. We retrospectively evaluated 88 intermediate-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50198fea70a444cdbfe9bfbfa1da0c4d
https://pubmed.ncbi.nlm.nih.gov/36551623
https://pubmed.ncbi.nlm.nih.gov/36551623
Autor:
Rie Ibusuki, Hirofumi Uto, Kohei Oda, Akihiko Ohshige, Kazuaki Tabu, Seiichi Mawatari, Kotaro Kumagai, Shuji Kanmura, Tsutomu Tamai, Akihiro Moriuchi, Hirohito Tsubouchi, Akio Ido
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0174913 (2017)
Neutrophil infiltration of the liver is a typical feature of alcoholic liver injury. Human neutrophil peptide (HNP)-1 is an antimicrobial peptide secreted by neutrophils. The aim of this study was to determine if HNP-1 affects ethanol-induced liver i
Externí odkaz:
https://doaj.org/article/3fcd7cd994b040e89977b5e26e5b349f
Publikováno v:
In Hepatology 2001 34(4) Part 2:A521-A521
Autor:
Sho, Ijuin, Kohei, Oda, Seiichi, Mawatari, Ohki, Taniyama, Ai, Toyodome, Haruka, Sakae, Kazuaki, Tabu, Kotaro, Kumagai, Shuji, Kanmura, Tsutomu, Tamai, Akihiro, Moriuchi, Hirofumi, Uto, Akio, Ido
Publikováno v:
Molecular and Clinical Oncology
The prevalence of non-alcoholic fatty liver disease (NAFLD) is continuously increasing, with the proportion of patients with liver carcinogenesis due to non-alcoholic steatohepatitis (NASH) rising accordingly. Although it is important to identify ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3400fa57a409654c06ee8e7f3456de25
https://doi.org/10.3892/mco.2021.2488
https://doi.org/10.3892/mco.2021.2488